Virtual Meeting to be held on March 3 hosted by Needham.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMRA:
- Neumora upgraded to Outperform from Market Perform at William Blair
- Differentiated NMRA-511 Efficacy and Safety in Alzheimer’s Agitation Support Buy Rating on Neumora
- Strengthening NMRA-511 Clinical Profile and Upside Potential Underpin Buy Rating and $18 Target
- Neumora outlines 2026 neuroscience pipeline and obesity plans
- Diversified CNS Pipeline and NLRP3 Opportunity Drive Upside in Neumora: Justifying an Outperform/Buy Rating